Abstract:The consortium of microbes inhabiting the human body, together with their encoded genes and secreted metabolites, is referred to as the “human microbiome.” Several studies have established a link between the composition of the microbiome and its impact on human health. This impact spans local gastrointestinal inflammation to systemic autoimmune disorders and neurodegenerative diseases such as Alzheimer’s and Autism. Some of these links have been validated by rigorous experiments that identify specific strains as mediators or drivers of a particular condition. Consequently, the development of probiotics to compensate for a missing beneficial microbe(s) has advanced and become popular, especially in the treatment of irritable bowel diseases and to restore disrupted gut flora after antibiotic administration. The widespread use of probiotics is often advocated as a natural ecological therapy. However, this perception is not always accurate, as there is a potential for unexpected interactions when administering live microbial cultures. Here, we designed this research to explore the intricate interactions among probiotics, the host, and microbes through a series of experiments. Our objectives included assessing their immunomodulatory effects, response to oral medications, impact on microbial population dynamics, and mediation of antibiotic resistance. To achieve these goals, we employed diverse experimental protocols, including cell-based enzyme -linked immunosorbent assay (ELISA), antibiotic susceptibility testing, antimicrobial activity assays, computational prediction of probiotic genes responsible for antibiotic resistance, polymerase chain reaction (PCR)-based validation of predicted genes, and survival assays of probiotics in the presence of selected oral medications. Our findings highlight that more than half of the tested probiotics trigger an inflammatory response in the Caco-2 cell line, are influenced by oral medications, exhibit antibacterial activity, and possess genes encoding antimicrobial resistance. These results underscore the necessity for a reevaluation of probiotic usage and emphasize the importance of establishing regulations to govern probiotic testing, approval, and administration.

Genetic Engineering of Probiotic Microorganisms

Safety Considerations and Genic Modification of Probiotics

Probiotic characterization of <i>Bacillus smithii</i>: Research advances, concerns, and prospective trends

Probiotic Role and Application of Thermophilic Bacillus As Novel Food Materials

Advanced probiotics: bioengineering and their therapeutic application

Gene editing and genetic engineering approaches for advanced probiotics: A review

Next generation probiotics: Engineering live biotherapeutics

Metabolic Engineering Approaches for Improvement of Probiotics Functionality

Exploring Probiotic Potential: A Comparative Genomics and In Silico Assessment of Genes within the Genus Geobacillus

Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study

Genetic Engineering of Resident Bacteria in the Gut Microbiome

Advancements in gene editing technologies for probiotic-enabled disease therapy

Genetically Engineered Microorganisms and Their Impact on Human Health

Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463

Engineering Diagnostic and Therapeutic Gut Bacteria

Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered S. boulardii

Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic Abnormality

CRISPR-Cas-Based Engineering of Probiotics

Probiotics and gastrointestinal disease: successes, problems and future prospects

Bioengineered probiotics, a strategic approach to control enteric infections

Probiotics Modulate Host Immune Response and Interact with the Gut Microbiota: Shaping Their Composition and Mediating Antibiotic Resistance